As of 2026-04-02, the Intrinsic Value of Eckert & Ziegler Strahlen und Medizintechnik AG (EUZ.DE) is 11.01 EUR. This EUZ.DE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 15.15 EUR, the upside of Eckert & Ziegler Strahlen und Medizintechnik AG is -27.30%.
The range of the Intrinsic Value is 8.59 - 16.20 EUR
Based on its market price of 15.15 EUR and our intrinsic valuation, Eckert & Ziegler Strahlen und Medizintechnik AG (EUZ.DE) is overvalued by 27.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 8.59 - 16.20 | 11.01 | -27.3% |
| DCF (Growth 10y) | 11.02 - 20.48 | 14.05 | -7.3% |
| DCF (EBITDA 5y) | 13.80 - 20.72 | 15.61 | 3.1% |
| DCF (EBITDA 10y) | 15.39 - 24.04 | 17.90 | 18.2% |
| Fair Value | 7.51 - 7.51 | 7.51 | -50.41% |
| P/E | 14.83 - 15.50 | 15.13 | -0.1% |
| EV/EBITDA | 12.74 - 19.32 | 15.73 | 3.8% |
| EPV | 6.42 - 8.29 | 7.35 | -51.5% |
| DDM - Stable | 5.05 - 13.73 | 9.39 | -38.0% |
| DDM - Multi | 7.76 - 16.08 | 10.43 | -31.1% |
| Market Cap (mil) | 962.33 |
| Beta | 1.28 |
| Outstanding shares (mil) | 63.52 |
| Enterprise Value (mil) | 887.79 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.39% |
| Cost of Debt | 4.25% |
| WACC | 8.08% |